Medicare Modernization: Catalyst for Risk and Opportunity
- Topics:
- Healthcare Services
- Tags:
- Benefits,
- Cisco Catalyst,
- Enterprise Software,
- Health Care,
- Healthcare,
- Human Resources,
- Medicare,
- Software,
- Vertical Industries
- Source:
- Ernst & Young
FREE Registration is required
Overview: Regulations are churning to operationalize the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA). First steps focus providing Medicare beneficiaries - primarily older Americans and persons with disabilities - with a prescription drug benefit. This expansion creates a new roadmap for the health sciences industry as Medicare progresses from providing a limited outpatient drug benefit to offering a discount card and, ultimately, a voluntary drug benefit in 2006. For pharma companies, MMA marks a turning point. Not only will the market for pharma's products expand, but the marketplace in which they operate will draw them into a complex and rapidly changing health care delivery system.
(Is this item miscategorized? Does it need more tags? Let us know.)
Format: PDF | Size: 494KB | Date: Apr 2005 | Pages: 4
